
The pipeline of emerging medicines for cancer cachexia. By my count, there are 20 drugs in clinical trials, with 14 distinct mechanisms -- 9 of them focussed on the GDF15–GFRAL pathway, including two bispecifics (GDF15 × IL-6 and GDF15 × NGF). There is even a vagus nerve-blocking device, that's now in phase 1!






















